Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization

Nature Medicine
M D LubeckMarjorie Robert-Guroff

Abstract

A combination AIDS vaccine approach consisting of priming with adenovirus-HIV-1MN gp160 recombinants followed by boosting with HIV-1SF2 gp120 was evaluated in chimpanzees. Long-lasting protection, requiring only three immunizations, was achieved against a low-dose challenge with the SF2 strain of HIV-1 and a subsequent high-dose SF2 challenge administered 1 year later without an intervening boost. Notably, neutralizing antibody responses against both clinical and laboratory isolates developed in three chimpanzees and persisted until the time of high-dose challenge. The possibility that cytotoxic T-lymphocytes contribute to low-dose protection of a chimpanzee lacking neutralizing antibodies is suggested. Our results validate the live vector priming/subunit booster approach and should stimulate interest in assessing this combination vaccine approach in humans.

References

Oct 3, 1991·Nature·E J Stott
Jan 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·M GirardE Muchmore
Jul 1, 1990·AIDS Research and Human Retroviruses·N L HaigwoodK S Steimer
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·P W BermanL A Lasky
Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M D LubeckP P Hung
Dec 1, 1993·AIDS Research and Human Retroviruses·C J ScandellaB Chapman
May 1, 1993·AIDS Research and Human Retroviruses·R J NatukS Mizutani
Dec 1, 1995·AIDS Research and Human Retroviruses·S Zolla-Pazner, S Sharpe

❮ Previous
Next ❯

Citations

Oct 3, 1999·Vaccine·M Klein
Aug 11, 2001·Current Opinion in Immunology·J R Mascola, G J Nabel
Oct 19, 2005·Gene Therapy·P GalloP Monaci
Feb 13, 2013·The Journal of Experimental Medicine·Laura E McCoy, Robin A Weiss
Mar 17, 2004·AIDS Research and Human Retroviruses·Nina MalkevitchMarjorie Robert-Guroff
Dec 5, 1998·AIDS Research and Human Retroviruses·J S Cairns, N Sarver
Apr 23, 2008·AIDS Research and Human Retroviruses·Laure Y JuompanFrancis J Novembre
Jul 23, 2005·Viral Immunology·Michael SantosuossoZhou Xing
Jan 31, 2002·AIDS·A M Schultz, J A Bradac
Feb 12, 1999·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·H OhnimusC Jassoy
Jan 18, 2013·Journal of Virology·Monica VaccariGenoveffa Franchini
Feb 19, 1999·Journal of Clinical Pathology·J S OxfordR Lambkin
Jan 27, 2011·Drug Design, Development and Therapy·Lena J Gamble, Qiana L Matthews

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.